EFFICACY AND SAFETY OF SECUKINUMAB IN JUVENILE IDIOPATHIC ARTHRITIS: INTERIM RESULTS FROM THE EXTENSION OF THE JUNIPERA TRIAL

被引：1

作者：

Ruperto, N. ^{[1
]}

Foeldvari, I. ^{[2
]}

Alexeeva, E. ^{[3
]}

Ayaz, N. Aktay ^{[4
]}

Schulert, G. ^{[5
]}

Ozen, S. ^{[6
]}

Popov, A. ^{[7
]}

Ramanan, A. ^{[8
]}

Scott, C. ^{[9
]}

Sozeri, B. ^{[10
]}

Zholobova, E. ^{[11
]}

Chakraborty, S. ^{[12
]}

Zhu, X. ^{[13
]}

Martin, R. ^{[14
]}

Whelan, S.

Kaur, S. ^{[15
]}

Pricop, L. ^{[13
]}

Lovell, D. J. ^{[5
]}

Martini, A. ^{[16
]}

Brunner, H. ^{[5
]}

机构：

[1] IRCCS Ist Giannina Gaslini, UOSID Ctr Trial, Genoa, Italy

[2] Hamburger Zentrum fuer Kinder & Jugendrheumatol, Rheumatol, Hamburg, Germany

[3] Natl Sci & Pract Ctr Childrens Hlth, Rheumatol, Moscow, Russia

[4] Istanbul Univ Cerrahpasa, Pediat Rheumatol, Fac Med, Istanbul, Turkiye

[5] Univ Cincinnati, Cincinnati Childrens Hosp, UC Dept Pediat, Cincinnati, OH USA

[6] Hacettepe Univ, Rheumatol, Med Fac, Ankara, Turkiye

[7] Ural State Med Univ Ekaterinburg, Rheumatol, Ekaterinburg, Russia

[8] Univ Bristol, Bristol Royal Hosp Children & Translat Hlth Sci, Bristol, Avon, England

[9] Univ Cape Town, Red Cross War Mem Childrens Hosp, Paediat Rheumatol, Cape Town, South Africa

[10] Univ Hlth Sci, Umraniye Training & Res Hosp, Div Pediat Rheumatol, Istanbul, Turkiye

[11] First Moscow State Med Univ, Moscow, Russia

[12] IQVIA, Durrham, NC USA

[13] Novartis Pharmaceut, E Hanover, NJ USA

[14] Novartis Ireland Ltd, Immunol, Dublin, Ireland

[15] Novartis Pharma AG, Immunol, Basel, Switzerland

[16] Univ Genoa, Rheumatol, Genoa, Italy

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷

关键词：

bDMARD; Clinical Trials;

D O I：

10.1136/annrheumdis-2023-eular.3679

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0278

引用

页码：379 / 380

页数：2

共 50 条

[1] Efficacy and Safety of Secukinumab in Juvenile Idiopathic Arthritis: Interim Results from the Extension of the JUNIPERA Trial
Brunner, Hermine
Foeldvari, Ivan
Alexeeva, Ekaterina
Ayaz, Nuray Aktay
Schulert, Grant
Ozen, Seza
Popov, Artem
Ramanan, Athimalaipet V.
Scott, Christiaan
Sozeri, Betul
Zholobova, Elena
Chakraborty, Sudhanshu
Zhu, Xuan
Martin, Ruvie
Whelan, Sarah
Kaur, Sharonjeet
Pricop, Luminita
Lovell, Daniel J.
Martini, Alberto
Ruperto, Nicolino
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 729 - 731
[2] EFFICACY AND SAFETY OF SECUKINUMAB TREATMENT IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS
Kriulin, I.
Alexeeva, E.
Dvoryakovskaya, T.
Isaeva, K.
Chomakhidze, A.
Chistyakova, E.
Lomakina, O.
Denisova, R.
Mamutova, A.
Fetisova, A.
Gautier, M.
Vankova, D.
Krekhova, E.
Shingarova, M.
Alshevskaya, A.
Moskalev, A.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 485 - 485
[3] Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis: Results from the Phase 3 Extension Study
Brunner, Hermine I.
Ruperto, Nicolino
Quartier, Pierre
Constantin, Tamas
Alexeeva, Ekaterina
Kone-Paut, Isabelle
Marzan, Katherine
Wulffraat, Nico
Schneider, Rayfel
Padeh, Shai
Chasnyk, Vyacheslav
Wouters, Carine
Kuemmerle-Deschner, Jasmin B.
Kallinich, Tilmann
Lauwerys, Bernard
Haddad, Elie
Nasonov, Evgeny
Trachana, Maria
Vougiouka, Olga
Leon, Karolynn
Speziale, Antonio
Lheritier, Karine
Martini, Alberto
Lovell, Daniel
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[4] Secukinumab for juvenile idiopathic arthritis
Brooks, Helen
Clark, Anna
Van Epps, Heather
LANCET RHEUMATOLOGY, 2021, 3 (08): : E551 - E551
[5] Efficacy of Secukinumab in Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis Subtypes of Juvenile Idiopathic Arthritis: Results from a Randomized, Phase 3 Study
Brunner, Hermine
Chertok, Elena
Dehoorne, Joke
Horneff, Gerd
Kallinich, Tilmann
Louw, Ingrid
Alessio, Maria
Compeyrot-Lacassagne, Sandrine
Lauwerys, Bernard
Martin, Neil
Marzan, Katherine
Knibbe, W. Patrick
Martin, Ruvie
Zhu, Xuan
Whelan, Sarah
Pricop, Luminita
Lovell, Daniel
Martini, Alberto
Ruperto, Nicola
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4382 - 4385
[6] EFFICACY AND SAFETY OF SECUKINUMAB IN ENTHESITIS-RELATED ARTHRITIS AND JUVENILE PSORIATIC ARTHRITIS: PRIMARY RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREATMENT WITHDRAWAL, PHASE 3 STUDY (JUNIPERA)
Ruperto, N.
Foeldvari, I.
Alexeeva, E.
Aktay Ayaz, N.
Calvo, I.
Kasapcopur, O.
Chasnyk, V.
Hufnagel, M.
Zuber, Z.
Schulert, G.
Ozen, S.
Popov, A.
Ramanan, A.
Scott, C.
Sozeri, B.
Zholobova, E.
Zhu, X.
Whelan, S.
Pricop, L.
Ravelli, A.
Martini, A.
Lovell, D. J.
Brunneron, H.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 201 - 202
[7] Secukinumab Therapy in Refractory Juvenile Idiopathic Arthritis
Nelson, Meghan Corrigan
Manos, Cynthia K.
JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2023, 11
[8] EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: DATA FROM A PHASE 3 TRIAL
De Benedetti, F.
Ruperto, N.
Zuber, Z.
Keane, C.
Harari, O.
Kenwright, A.
Cuttica, R.
Keltsev, V.
Xavier, R.
Calvo, I.
Nikishina, I.
Rubio-Perez, N.
Alekseeva, E.
Chasnyk, V.
Chavez, J.
Horneff, G.
Opoka-Winiarska, V.
Quartier, P.
Silva, C.
Silverman, E.
Spindler, A.
Martini, A.
Lovell, D.
Brunner, H.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 70 - 70
[9] Long-Term Effectiveness and Safety of Abatacept in Juvenile Idiopathic Arthritis: Interim Results from the Abatacept in JIA Registry
Lovell, Daniel J.
Ruperto, N.
Spalding, S.
Dare, J. A.
Cimaz, R.
Stanevica, V.
Vehe, R. K.
Tzaribachev, N.
Horneff, G.
Trachana, M.
Simon, T. A.
Brunner, H. I.
Martini, A.
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[10] Long-Term Effectiveness and Safety of Abatacept in Juvenile Idiopathic Arthritis: Interim Results from the Abatacept in JIA Registry
Lovell, D. J.
Ruperto, N.
Tzaribachev, N.
Zeft, A.
Cimaz, R.
Stanevica, V.
Horneff, G.
Bohnsack, J.
Griffin, T. A.
Carrasco, R.
Trachana, M.
Dare, J. A.
Foeldvari, I.
Vehe, R. K.
Simon, T. A.
Baker, N.
Brunner, Hermine I.
Martini, A.
ARTHRITIS & RHEUMATOLOGY, 2016, 68

← 1 2 3 4 5 →